|
Universal Donor (UD) TGFβi NK Cells Clinical Trials
1 actively recruiting trial across 1 location
Los Angeles, California1 trial
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
Children's Hospital Los Angeles
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.